Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416493067> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2416493067 endingPage "32" @default.
- W2416493067 startingPage "e325" @default.
- W2416493067 abstract "To investigate adherence, persistence, and switching in patients initiating dabigatran.Descriptive analysis using pharmacy claims databases.Patients with a claim for dabigatran and who were continuously enrolled in pharmacy benefits for 180 days prior to and 180 days following the initiation of dabigatran were identified and stratified by whether there was a history of warfarin treatment prior to dabigatran initiation. Medication adherence was calculated as the proportion of days covered (PDC). Persistence to treatment at 180 days was measured. Among patients who discontinued dabigatran, time to initiating warfarin was determined.In the overall population, 39.9% of 17,691 patients were nonpersistent to dabigatran. The PDC for the warfarin-naïve cohort was 0.674 (standard deviation [SD] 0.364), and 0.712 (SD 0.354) for the warfarin-experienced cohort. For patients persistent to dabigatran, the PDCs for warfarin-naïve and warfarin-experienced cohorts were 0.935 (SD 0.075) and 0.937 (SD 0.074), respectively. In patients discontinuing dabigatran, 16.1% of warfarin-naïve and 41.1% of warfarinexperienced patients initiated warfarin. Among patients discontinuing dabigatran, the mean time to discontinuation in warfarin-naïve and warfarinexperienced cohorts, respectively, was 59.8 (SD 36.2) and 59.6 (SD 36.2) days. The mean time to initiating warfarin in warfarin-naïve and warfarin experienced cohorts, respectively, was 62.5 (SD 47.2) and 60.5 (SD 43.0) days.Two in 5 patients discontinued dabigatran therapy within 6 months, and the majority of these patients were not anticoagulated with warfarin upon discontinuation. These findings highlight potential gaps in the care of patients treated with dabigatran in routine practice." @default.
- W2416493067 created "2016-06-24" @default.
- W2416493067 creator A5002731655 @default.
- W2416493067 creator A5026797433 @default.
- W2416493067 creator A5029986618 @default.
- W2416493067 creator A5035118554 @default.
- W2416493067 creator A5054913342 @default.
- W2416493067 creator A5081254305 @default.
- W2416493067 date "2013-09-01" @default.
- W2416493067 modified "2023-09-27" @default.
- W2416493067 title "Adherence, persistence, and switching patterns of dabigatran etexilate." @default.
- W2416493067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24449962" @default.
- W2416493067 hasPublicationYear "2013" @default.
- W2416493067 type Work @default.
- W2416493067 sameAs 2416493067 @default.
- W2416493067 citedByCount "16" @default.
- W2416493067 countsByYear W24164930672013 @default.
- W2416493067 countsByYear W24164930672014 @default.
- W2416493067 countsByYear W24164930672015 @default.
- W2416493067 countsByYear W24164930672016 @default.
- W2416493067 countsByYear W24164930672017 @default.
- W2416493067 countsByYear W24164930672018 @default.
- W2416493067 countsByYear W24164930672019 @default.
- W2416493067 countsByYear W24164930672021 @default.
- W2416493067 countsByYear W24164930672023 @default.
- W2416493067 crossrefType "journal-article" @default.
- W2416493067 hasAuthorship W2416493067A5002731655 @default.
- W2416493067 hasAuthorship W2416493067A5026797433 @default.
- W2416493067 hasAuthorship W2416493067A5029986618 @default.
- W2416493067 hasAuthorship W2416493067A5035118554 @default.
- W2416493067 hasAuthorship W2416493067A5054913342 @default.
- W2416493067 hasAuthorship W2416493067A5081254305 @default.
- W2416493067 hasConcept C104863432 @default.
- W2416493067 hasConcept C126322002 @default.
- W2416493067 hasConcept C2776301958 @default.
- W2416493067 hasConcept C2778715236 @default.
- W2416493067 hasConcept C2778810321 @default.
- W2416493067 hasConcept C2779161974 @default.
- W2416493067 hasConcept C2908647359 @default.
- W2416493067 hasConcept C42219234 @default.
- W2416493067 hasConcept C512399662 @default.
- W2416493067 hasConcept C71924100 @default.
- W2416493067 hasConcept C72563966 @default.
- W2416493067 hasConcept C99454951 @default.
- W2416493067 hasConceptScore W2416493067C104863432 @default.
- W2416493067 hasConceptScore W2416493067C126322002 @default.
- W2416493067 hasConceptScore W2416493067C2776301958 @default.
- W2416493067 hasConceptScore W2416493067C2778715236 @default.
- W2416493067 hasConceptScore W2416493067C2778810321 @default.
- W2416493067 hasConceptScore W2416493067C2779161974 @default.
- W2416493067 hasConceptScore W2416493067C2908647359 @default.
- W2416493067 hasConceptScore W2416493067C42219234 @default.
- W2416493067 hasConceptScore W2416493067C512399662 @default.
- W2416493067 hasConceptScore W2416493067C71924100 @default.
- W2416493067 hasConceptScore W2416493067C72563966 @default.
- W2416493067 hasConceptScore W2416493067C99454951 @default.
- W2416493067 hasIssue "9" @default.
- W2416493067 hasLocation W24164930671 @default.
- W2416493067 hasOpenAccess W2416493067 @default.
- W2416493067 hasPrimaryLocation W24164930671 @default.
- W2416493067 hasRelatedWork W1949360939 @default.
- W2416493067 hasRelatedWork W1964382777 @default.
- W2416493067 hasRelatedWork W2016226059 @default.
- W2416493067 hasRelatedWork W2171284718 @default.
- W2416493067 hasRelatedWork W2416493067 @default.
- W2416493067 hasRelatedWork W2800941304 @default.
- W2416493067 hasRelatedWork W2802930797 @default.
- W2416493067 hasRelatedWork W2883573830 @default.
- W2416493067 hasRelatedWork W2991690544 @default.
- W2416493067 hasRelatedWork W4228999874 @default.
- W2416493067 hasVolume "19" @default.
- W2416493067 isParatext "false" @default.
- W2416493067 isRetracted "false" @default.
- W2416493067 magId "2416493067" @default.
- W2416493067 workType "article" @default.